Oridonin exhibits anti-angiogenic activity in human umbilical vein endothelial cells by inhibiting VEGF-induced VEGFR-2 signaling pathway

This publication has 40 references indexed in Scilit:

• RETRACTED ARTICLE: α-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathway
  Molecular Cancer, 2013
• Tylophorine, a phenanthraindolizidine alkaloid isolated from Tylophora indica exerts antiangiogenic and antitumor activity by targeting vascular endothelial growth factor receptor 2–mediated angiogenesis
  Molecular Cancer, 2013
• Quercetin Inhibits Angiogenesis Mediated Human Prostate Tumor Growth by Targeting VEGFR- 2 Regulated AKT/mTOR/P70S6K Signaling Pathways
  PLOS ONE, 2012
• Celastrol inhibits vasculogenesis by suppressing the VEGF-induced functional activity of bone marrow-derived endothelial progenitor cells
  Biochemical and Biophysical Research Communications, 2012
• Lycopene inhibits angiogenesis both in vitro and in vivo by inhibiting MMP‐2/uPA system through VEGFR2‐mediated PI3K‐Akt and ERK/p38 signaling pathways
  Molecular Nutrition & Food Research, 2012
• Arenobufagin, a bufadienolide compound from toad venom, inhibits VEGF-mediated angiogenesis through suppression of VEGFR-2 signaling pathway
  Biochemical Pharmacology, 2012
• Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor‐2
  British Journal of Pharmacology, 2011
• PI3K/AKT/mTOR Pathway in Angiogenesis
  Frontiers in Molecular Neuroscience, 2011
• Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
  Journal of Clinical Oncology, 2005
• Role of angiogenesis in tumor growth and metastasis
  Seminars in Oncology, 2002